| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Replacement of the C6ORF66 assembly factor (NDUFAF4) restores complex I activity in patient cells. | Mol Med | 2013 | 0.85 |
| 2 | α-Synuclein expression selectively affects tumorigenesis in mice modeling Parkinson's disease. | PLoS One | 2011 | 0.84 |
| 3 | IL2-caspase3 chimeric protein controls lymphocyte reactivity by targeted apoptosis, leading to amelioration of experimental autoimmune encephalomyelitis. | Int Immunopharmacol | 2009 | 0.80 |
| 4 | IL-2-granzyme A chimeric protein overcomes multidrug resistance (MDR) through a caspase 3-independent apoptotic pathway. | Int J Cancer | 2011 | 0.76 |
| 5 | Eliminating the six N-terminal amino acids of the caspase 3 large subunit improved production of a biologically active IL2-Caspase3 chimeric protein. | Biotechnol Prog | 2012 | 0.75 |